ADMA Biologics, Inc. (ADMA)
11.76
+0.48
(+4.21%)
USD |
NASDAQ |
Oct 29, 16:00
11.69
-0.06
(-0.55%)
After-Hours: 18:36
ADMA Biologics Total Return Level : 11.28 for Oct. 28, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 28, 2026 | 11.28 |
| October 27, 2026 | 11.17 |
| October 26, 2026 | 11.06 |
| October 23, 2026 | 10.68 |
| October 22, 2026 | 10.95 |
| October 21, 2026 | 11.01 |
| October 20, 2026 | 11.23 |
| October 19, 2026 | 11.07 |
| October 16, 2026 | 10.68 |
| October 15, 2026 | 10.73 |
| October 14, 2026 | 10.34 |
| October 13, 2026 | 10.31 |
| October 12, 2026 | 10.18 |
| October 09, 2026 | 10.36 |
| October 08, 2026 | 10.33 |
| October 07, 2026 | 10.14 |
| October 06, 2026 | 10.18 |
| October 05, 2026 | 10.11 |
| October 02, 2026 | 9.72 |
| October 01, 2026 | 9.93 |
| September 30, 2026 | 10.03 |
| September 29, 2026 | 9.96 |
| September 28, 2026 | 10.12 |
| September 25, 2026 | 9.38 |
| September 24, 2026 | 9.52 |
| Date | Value |
|---|---|
| September 23, 2026 | 9.70 |
| September 22, 2026 | 9.81 |
| September 21, 2026 | 9.505 |
| September 18, 2026 | 9.11 |
| September 17, 2026 | 8.95 |
| September 16, 2026 | 8.90 |
| September 15, 2026 | 8.61 |
| September 14, 2026 | 9.14 |
| September 11, 2026 | 9.23 |
| September 10, 2026 | 9.39 |
| September 09, 2026 | 9.45 |
| September 08, 2026 | 9.54 |
| September 04, 2026 | 9.62 |
| September 03, 2026 | 9.58 |
| September 02, 2026 | 9.51 |
| September 01, 2026 | 9.33 |
| August 31, 2026 | 9.39 |
| August 28, 2026 | 9.34 |
| August 27, 2026 | 9.48 |
| August 26, 2026 | 9.63 |
| August 25, 2026 | 9.72 |
| August 24, 2026 | 9.55 |
| August 21, 2026 | 9.84 |
| August 20, 2026 | 9.76 |
| August 19, 2026 | 10.05 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Vericel Corp. | 41.09 |
| BioMarin Pharmaceutical, Inc. | 56.00 |
| Emergent BioSolutions, Inc. | 7.09 |
| Exelixis, Inc. | 66.28 |
| Akebia Therapeutics, Inc. | 0.7646 |